Previous close | 43.85 |
Open | 44.22 |
Bid | 43.94 x 400 |
Ask | 44.09 x 100 |
Day's range | 43.49 - 44.44 |
52-week range | 27.99 - 50.99 |
Volume | |
Avg. volume | 421,724 |
Market cap | 3.318B |
Beta (5Y monthly) | 1.26 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.72 |
Earnings date | 07 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 58.32 |
Key Insights Using the 2 Stage Free Cash Flow to Equity, Xenon Pharmaceuticals fair value estimate is US$55.22 Current...
Longboard (LBPH) gains 14% as the FDA grants the Breakthrough Therapy designation to its investigational epilepsy treatment candidate, bexicaserin, for patients aged two years or older.
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Xenon Pharmaceuticals Inc. (NASDAQ:XENE) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]